Advantages in the Primary Prevention of Alzheimer's Disease
Although the focus of Alzheimer's disease (AD) research efforts remains on finding a treatment that slows disease progression and recovers cognitive decline, interest in primary prevention of the disease is growing, especially because there are several confounding, modifiable factors believed to be associated with elevated risk of AD.1,2
“It is important to recognize that AD begins in the brain prior to clinically apparent symptoms. This preclinical phase may be our best opportunity for successful treatment in AD,” said Reisa Sperling, MD, of Harvard Medical School, Brigham and Women's Hospital, and Massachusetts General Hospital in Boston.